Back to results
US 7,598,058 B2Granted
Nucleic acids encoding IL13 mutants
AssigneeThe Penn State Research Foundation
InventorsWaldemar Debinski, Jeffrey P. Thompson
Life of this patent
Estimating the term…
Abstract
This invention provides nucleic acid molecules encoding mutant human interleukin 13 molecules showing varying specificity for the restricted (IL4 independent) IL13 receptor. The mutant hIL13 molecules include those made by substituting the amino acid residues that occur in the alpha-helix regions of native hIL13 with various other amino acid residues. Some of the mutants retain the ability to bind and cause signaling through IL13 receptors, while other mutants do not.
Claims1
An isolated polynucleotide, encoding a chimeric molecule comprising:
- (a) a human IL13 polypeptide having a mutation and able to bind a shared IL13/4 receptor with less affinity than native hIL13 binds the shared IL13/4 receptor;
- and, (b) an effector molecule selected from the group consisting of:
- a cytotoxin and a detectable label,
- wherein the human IL13 polypeptide has the amino acid sequence set forth in SEQ ID NO:
- 2.
2 more elements
Dependencies are inferred from the claim text.